Delivery Order SPE2DB20D2104-SPE2DB21FS56Y
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of a wide range of pharmaceutical products and medical supplies to support Defense Logistics Agency (DLA) Troop Support Medical. The $12,338.50 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA. This single-award IDC serves as the primary vehicle for the company to provide critical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,975.48, is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, worth up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,764.06 for the supply of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,091.76, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA worth up to $999,999,999.00 through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive assortment of medications,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides pharmaceutical products and medical supplies to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The $2,753.63 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA and Amerisourcebergen, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the provision of a wide range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $9,249.32 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by the company's parent organization, Cencora, Inc. This IDC serves as the primary vehicle for Amerisourcebergen to deliver critical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a variety of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $9,843.63 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medications, including...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, supports the supply of a comprehensive range of medical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,394.64, is a delivery order under an Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with the DLA. This IDC serves as the primary vehicle for the company to deliver pharmaceutical and medical supplies,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs. The contract, valued at $7,925.64, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for a Delivery Order valued at $1,356.79 to provide a broad range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB21FS56YDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $9,714.99 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA, which runs through November 2026. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company, Cencora, Inc., also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 4/26/21 |